Sigma-Aldrich Corp. (SIAL, Financial)(4.4%) (SIAL – $138.92 – NASDAQ) is a leading life science and technology company based in St. Louis, Missouri that manufactures and distributes more than 230,000 chemicals, biochemical, and other essential products to more than 1.4 million customers globally. On September 22, 2014, Merck KGaA, a German multinational pharmaceutical and chemical company, announced that it would acquire Sigma-Aldrich for $16.7 billion, or $140 cash per share. The deal received shareholder and regulatory approvals and should close within the next two months, pending completion of divestitures in the EU.
From Mario Gabelli (Trades, Portfolio)'s third quarter 2015 ABC Fund commentary.
